Radiation therapy firm Accuray said that more than 70 abstracts reporting on the use of its CyberKnife and TomoTherapy technologies were presented at the annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Copenhagen this week.
Studies were presented detailing CyberKnife's utility in neurological disorders and breast cancer, for example, according to the company. Meanwhile, other researchers shared findings on TomoTherapy's TomoHelical treatment delivery for treating multiple myeloma, anal cancer, nonmetastatic cervical cancer, and multiple painful bone metastases, according to the vendor.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
